Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Oct 17, 2024

BUY
$191.17 - $325.63 $85.4 Million - $145 Million
446,611 New
446,611 $145 Million
Q1 2024

Aug 16, 2024

BUY
$191.17 - $325.63 $8.65 Million - $14.7 Million
45,226 Added 11.27%
446,611 $145 Million
Q1 2024

May 15, 2024

BUY
$191.17 - $325.63 $8.65 Million - $14.7 Million
45,226 Added 11.27%
446,611 $145 Million
Q4 2023

Aug 16, 2024

BUY
$160.99 - $215.69 $64.6 Million - $86.6 Million
401,385 New
401,385 $76.5 Million
Q4 2023

Feb 13, 2024

SELL
$160.99 - $215.69 $4.69 Million - $6.28 Million
-29,110 Reduced 6.76%
401,385 $76.5 Million
Q3 2023

Nov 15, 2023

BUY
$194.33 - $283.97 $2.75 Million - $4.02 Million
14,164 Added 3.4%
430,495 $85.7 Million
Q2 2023

Aug 14, 2023

BUY
$223.05 - $302.68 $5.73 Million - $7.78 Million
25,701 Added 6.58%
416,331 $119 Million
Q1 2023

May 15, 2023

BUY
$175.41 - $217.92 $19.2 Million - $23.8 Million
109,362 Added 38.88%
390,630 $84.7 Million
Q4 2022

Feb 14, 2023

SELL
$204.38 - $296.82 $15.9 Million - $23.1 Million
-77,808 Reduced 21.67%
281,268 $57.8 Million
Q3 2022

Nov 14, 2022

BUY
$195.21 - $310.53 $20.1 Million - $32 Million
103,019 Added 40.23%
359,076 $99.8 Million
Q2 2022

Oct 27, 2022

BUY
$115.91 - $214.48 $7.39 Million - $13.7 Million
63,763 Added 33.16%
256,057 $49 Million
Q2 2022

Aug 15, 2022

BUY
$115.91 - $214.48 $7.39 Million - $13.7 Million
63,763 Added 33.16%
256,057 $49 Million
Q1 2022

Oct 27, 2022

SELL
$127.96 - $207.36 $8.16 Million - $13.2 Million
-63,763 Reduced 24.9%
192,294 $39.9 Million
Q1 2022

May 13, 2022

SELL
$127.96 - $207.36 $30.4 Million - $49.3 Million
-237,909 Reduced 55.3%
192,294 $39.9 Million
Q4 2021

Feb 14, 2022

SELL
$165.13 - $241.83 $7.71 Million - $11.3 Million
-46,683 Reduced 9.79%
430,203 $76.7 Million
Q3 2021

Nov 15, 2021

BUY
$163.99 - $235.57 $78.2 Million - $112 Million
476,886 New
476,886 $98.2 Million

Others Institutions Holding SWAV

About Shockwave Medical, Inc.


  • Ticker SWAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,927,100
  • Description
  • ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...
More about SWAV
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.